Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07684612 Mocertatug Rezetecan Platinum-Sensitive Ovarian Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07684612 Mocertatug Rezetecan Platinum-Sensitive Ovarian Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07684612 clinical trial report covering Mocertatug Rezetecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07682792 Golidocitinib Mycosis Fungoides Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07682792 Golidocitinib Mycosis Fungoides Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07682792 clinical trial report covering Golidocitinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07682675 Zanzalintinib Liver metastases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07682675 Zanzalintinib Liver metastases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07682675 clinical trial report covering Zanzalintinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07687433 Apatinib Mesylate Locally Advanced Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07687433 Apatinib Mesylate Locally Advanced Rectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687433 clinical trial report covering Apatinib Mesylate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07687056 Tenecteplase Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07687056 Tenecteplase Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687056 clinical trial report covering Tenecteplase, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
ChiCTR2600127792 Ibuprofen Fever Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600127792 Ibuprofen Fever Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
ChiCTR2600127792 clinical trial report covering Ibuprofen, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07688356 Belvarafenib BRAF mutation Solid Tumors Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07688356 Belvarafenib BRAF mutation Solid Tumors Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688356 clinical trial report covering Belvarafenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07687186 Qishen Yiqi Dropping Pills Chronic heart failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07687186 Qishen Yiqi Dropping Pills Chronic heart failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687186 clinical trial report covering Qishen Yiqi Dropping Pills, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07688213 VG-3927 Alzheimer Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07688213 VG-3927 Alzheimer Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688213 clinical trial report covering VG-3927, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07688772 Drotokibart Rhinitis, Allergic, Seasonal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07688772 Drotokibart Rhinitis, Allergic, Seasonal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688772 clinical trial report covering Drotokibart, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07687914 Palverafusp α Advanced Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07687914 Palverafusp α Advanced Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687914 clinical trial report covering Palverafusp α, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07686380 Nogapendekin alfa inbakicept-pmln Recurrent Prostate Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07686380 Nogapendekin alfa inbakicept-pmln Recurrent Prostate Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686380 clinical trial report covering Nogapendekin alfa inbakicept-pmln, Phase 2, endpoints, sponsor, geography, readout timing and development white spa
Read →